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ABSTRACT 
A three year retrospective case—control Istudy examined 
clinical and laboratory data of outpatients who had had 
bacterial blood cultures taken in the Yale—New Haven 
Hospital Emergency Room. Seventy-seven of the 79 patients 
(97.4%) with growth in at least one blood culture were 
studied. The 21 patients classified as true positives 
served as the case group for the study. Ninety-eight 
patients with no growth acted as unmatched controls. They 
represented a 10% random sample of all the patients without 
growth. Fifty-two patients were classified as 
contaminants. 
Rates were estimated at 357 outpatients cultured per 
year with 7 true positives per year (1.9% of all outpatient 
blood cultures) and 17 (4.9%) contaminants per year (4.9% of 
all outpatient blood cultures). 
Useful predictors for bacteremia include: 1) absolute 
band count greater than 2,000, 2) non-caucasian race, and 3) 
presence of pneumonia, urinary tract infection, or skin/soft 
tissue infection. All cases had one or more predictive 
factors, while only 54 (55.0%) of the controls did. Five 
(23.8%) of the cases had all three predictive factors, while 
only 2 (2.0%) of the controls did. The odds ratio for 
bacteremia increased to 23.7 with one predisposing factor, 
42.9 with two, and 195.8 with all three predisposing 
factors • 
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BACTEREMIA. The word conjures the vision of an 
extremely sick patient with hypotension, and prostration... 
virtually at death's door (46). 
Fortunately, not all bacteremia is that severe: It 
actually occurs as a spectrum with one extreme resembling 
the "septic" picture above and the other resembling the 
transient bacteremia that occurs daily secondary to brushing 
of teeth or a vigorous bowel movement. This study examines 
patients in the middle of the bacteremic spectrum: The ill 
but ambulatory patient with bacteremia. 
1.1.1 BACTEREMIA IN GENERAL 

2. 
Bacteremia is associated with a number of infections, 
including gonorrhea, pneumonia, cellulitis, and urinary 
tract infections. It is also associated with surgical 
procedures and instrumentation. Bacteria spreading from the 
primary site of infection to the blood can lead to sepsis, 
which carries a mortality rate as high as 25% (20). 
Although bacteremia may be suspected in a given 
clinical setting, the only way to prove it is to isolate a 
pathogen in a blood culture. No constellation of signs or 
symptoms is diagnostic of bacteremia. No definitive rules 
dictate how many blood cultures to take, or which patients 
to culture. The culture procedure may also vary from person 
to person. Typically, a fever work up includes two sets of 
blood cultures (four bottles, two aerobic and two 
anaerobic), but often only one set is taken. One study did 
examine the number of cultures needed to diagnose bacterial 
endocarditis (3). It concluded that most cases were detected 
with six bottles. Unfortunately, few such rules exist for 
the use of blood cultures in other infections. 
1.1.2 OUTPATIENT BACTEREMIA 
The outpatient bacteremic is ill, but not sick enough 
for admission to the hospital. This situation is not 
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uncommon in pediatrics, but some workers claim that in 
adults, this situation is impossible: Any adult who is 
bacteremic is sick enough to be admitted, at least for 
observation. However, the phenomenon of outpatient 
bacteremia in adults is documented at least twice in the 
literature (16, 44). 
1.1.2.1 ADULT OUTPATIENT BACTEREMIA 
The first group to look at outpatient bacteremia in 
adults was Eisenberg, et al., in 1976 (16). Blood cultures 
were collected from 210 of 565 febrile patients in the 
emergency room. Some of these patients were admitted and 
some discharged from the emergency room. Among those 
discharged, only one out of 124 (0.8%) was considered to 
have a true positive culture, and 4 (3.2%) were considered 
to have contaminated cultures. (Of the cultures with 
growth, 80% were contaminants). The positive culture rate 
was much higher in those admitted: 9 out of 86 (10.4%) 
compared with the 0.8% positive rate in outpatients. 
This information may lead one to speculate that 
bacteremia occurs rarely in outpatients. However, 
Eisenberg's study lacked precision on several counts: First, 
the source population was comprised of all adults who came 
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into the emergency room with fever. No mention was made as 
to whether the patients were selected because of suspected 
bacteremia. The only criterion seemed to be that the 
temperature was greater than 37.6° C. Since fevers in adults 
can result from causes other than bacteremia, one would 
expect an artificially low rate of positivity from this 
unfocused culturing. Secondly, only 30.9% of those eligible 
for the study were actually cultured. It is not stated 
whether this was a random sample or a convenience sample, or 
if some other criteria were used to select this 30.9%. 
Thirdly, the criteria used to determine contaminants were 
not clearly defined. 
A more recent two-part study by Stair, et al., focused 
on patients who had had blood cultures taken in the 
emergency room (44). One hundred consecutive outpatients who 
had had blood cultures taken were examined prospectively. 
Ten had positive blood cultures, but only 4 were considered 
true positives, giving a 4% positivity rate and a 6% 
contamination rate. In the second part of the study, 
records from 400 patients were studied retrospectively. 
Seventeen patients had growth in their blood cultures. Only 
two, however, were considered true positives, giving a 
positive rate of 0.5%. 
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1.1.2.2 PEDIATRIC OUTPATIENT BACTEREMIA 
Outpatient bacteremia has had more intensive study in 
pediatrics. In the early 1970s, the "new disease" of 
outpatient bacteremia was "discovered," probably because 
pediatricians began drawing more blood cultures to look for 
bacteremia secondary to pneumonia or meningococcus, and then 
sending the children home. Numerous studies have examined 
clinical correlates, including temperature, leukocyte count, 
and band count, and created indices based on these clinical 
findings to guide the clinician to the patients most likely 
to be bacteremic (4,5,13,19,25-31,36,40,45,50). 
1.2 PURPOSE 
The purpose of this study includes the following three 
goals: 
1. To approximate the rates at which blood cultures are 
taken in adult outpatients, along with the rates of 
positivity and contamination. 
2. To determine which factors may be correlated with the 
presence of bacteremia in outpatient adults. 
3. To create an index which may be useful in guiding the 
clinician in the decision of whether or not to take 




MATERIALS AND METHODS 
2.1 STUDY POPULATION 
The study population came from the emergency room of 
Yale-New Haven Hospital in New Haven, CT. This emergency 
room serves approximately 70,000 people per year, primarily 
from New Haven and surrounding towns. Of these, 
approximately 10,000 are admitted, and the remaining 60,000 
treated as outpatients. When a patient arrives, he or she 
is triaged into the appropriate area of the emergency room. 
The patients with medical complaints (as opposed to 
pediatric, gynecologic, or surgical complaints) are triaged 
to the medical area. This study draws only from the medical 
area which serves approximately 20,000 inpatients and 
outpatients per year. 
Outpatients who had had blood cultures taken in the 

emergency room medical services were identified by means of 
a source list made by the hospital computer information 
service. It listed all patients who had had blood cultures 
drawn in the emergency room between 1 February 1983 and 31 
January 1986. The listing provided patient name, unit 
number, culture number, and presence or absence of growth 
for the blood culture. If the patient had been discharged 
from the emergency room (the so called outpatient) his or 
her name would definitely appear on the list. However, 
since some people have blood cultures taken in the emergency 
room and then are admitted, some inpatients may appear on 
the list as well. Thus, the list of outpatients with blood 
cultures includes some inpatients. 
2.2 BLOOD CULTURE PROCEDURE 
If the house officer or attending physician suspects 
that the patient may be bacteremic, s/he may obtain blood 
for culture. This is done by first locating an adequate 
vein for venipuncture, preferably the antecubital vein. 
Ideally, the area is cleaned three times with a betadine 
solution. Ten milliliters (ml) of blood are taken; five ml 
are put into an aerobic culture bottle and five ml are put 
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into an anaerobic bottle. The needle is usually changed 
before each bottle is inoculated to avoid contamination. 
One aerobic bottle together with one anaerobic bottle is 
called a set of cultures. The culture procedure is not 
standardized; medical students, nurses, or other staff 
members may draw the cultures. The adequacy of cleaning the 
culture site, and the maintenance of sterile procedure 
varies from person to person and time to time. As discussed 
in the introduction, the indications for taking blood 
cultures are not uniform. 
The cultures are sent to the bacteriology laboratory 
where they are processed as follows: Aerobic bottles are 
filled to 13 times the head space with a mixture of 5% 
carbon dioxide and 95% air, and placed in a shaker apparatus 
in an incubator at 37.0° in order to hasten the growth of 
any organisms present. Anaerobic bottles are filled with 5% 
hydrogen, 10% carbon dioxide and 85% nitrogen and placed 
motionless in the incubator. 
Growth is detected using a Bac-Tek machine which 
samples the gas inside the bottles. Since the carbon 
substrates in the nutrient broth are radioactively labeled 
with any bacterial growth will result in radioactively 
labeled carbon dioxide (6,11). Thus, if growth has occurred, 
the Bac Tek machine will detect the radioactive CC^ and 
sound an alarm if the level is sufficiently above 
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background. When this occurs, a small amount of liquid 
growth media is taken from the culture bottle, fixed on a 
slide and gram stained. At this time subcultures are placed 
on selective and non-selective media. The house officer is 
notified of the gram stain results as soon as they are 
available. Final identification is usually available within 
72 hours and often as early as 24 hours. The bottles are 
tested for growth three times per day for the first two 
days, since the majority of growth appears during that 
time. After two days the cultures are tested only once per 
day. The blood culture lab processes between 45 and 60 sets 
of cultures a day and reports an overall positivity rate of 
five to nine percent. 
2.3 TYPE OF STUDY 
As stated in the introduction, the purpose of this 
study is two fold: 
1. To determine how many blood cultures are taken in the 
emergency room along with the rates of positivity and 
contamination. 
2. To determine what clinical or laboratory data may be 
helpful in predicting which patients are bacteremic. 
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These two approaches may necessitate different study 
designs: for rates, a cohort or cross-sectional study is 
needed in order to determine the denominator for the rates 
(23). This cohort could also be used to determine predictive 
factors, however, it may not be the most efficient study 
design to answer this question. For example, if the overall 
percent positivity were 5%, and the percent negative were 
!?5%, for every case, 19 non-cases would be available for 
comparison. While this may add to the overall power of the 
statistical analysis, it requires studying an impractical 
number of patients. Therefore, a case-control design may be 
more efficient for determining possible predictive factors. 
2.4 CASK-CONTROL STUDY 
The case-control design is used to study rare events 
(23). Since the overall rate of bacteremia in outpatients 
may be as low as 0.5%, it can be considered a rare event. 
Theretore the case-control approach is appropriate for 
detecting and quantifying differences in laboratory and 
clinical factors between bacteremic and non-bacteremic 
patients 

2.4.1 SELECTION OF CONTROLS 
One of the most critical parts of the case-control 
design is the selection of appropriate controls (23). 
Inappropriate controls may lead to erroneous conclusions. 
In this study, controls are selected from the group of 
people who fulfill all of the following criteria: 
1. Blood culture taicen in the emergency room between 1 
February 83 and 31 January 86, 
2. Not admitted from emergency room, 
3. No growth reported from blood culture. 
They differ from cases only in that their blood 
cultures grew no organisms (ie bacteremia was suspected but 
not detected). 
This control group does not represent the entire adult 
emergency room population, but only those who had blood 
cultures taken, that is those patients in which bacteremia 
is suspected. This limitation must be kept in mind later on 
when the results are applied to the study population. 
The source list contained all outpatients who had had 
cultures taken in the emergency room along with a few 
inpatients. To produce a control group, a 10^ random sample 
was taken from the patient's marked NG (no growth), using a 
random number table (33). This subset, too, contained both 
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outpatients and inpatients. Inpatients were identified and 
eliminated at this point by checking the admissions lists in 
medical records or by checking the patients medical record. 
Information from these patients was extracted as described 
in section 2.6. 
2.4.2 CASES AND CONTAMINANTS 
The source list marked all positive cultures as GROWTH. 
This subset included both true positives and false positives 
(contaminants). Contaminants may be from the skin (1), or 
from some other source of contact while obtaining the 
specimen, from the bottle itself (21), from the blood 
drawing equipment (15), or from the agar plates used for 
subculture. 
2.4.3 CASE DEFINITION 
The case definition used in this study includes the 
following four characteristics: 
1. Blood culture taken in the emergency room between 1 
February, 1^83 and 31 January, 1986. 
2. Patient not admitted from emergency room. 
3. Growth reported from blood culture. 
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4 . Growth determined not to be a contaminant. 
The first three characteristics are fairly straightforward, 
however, the fourth needs a better definition, namely what 
is a contaminant. This will be discussed in the following 
section. 
2.5 CRITERIA FOR DIFFERENTIATING CASES AND CONTAMINANTS 
Many researchers consider all coagulase negative 
Staphylococcus, Bacillis species and diphtheroids as 
contaminants. However, doing so may inadvertently eliminate 
occasional true positives. All of these so called 
contaminants may cause bacteremia. In fact, one study found 
that 33 out of 437 patients who grew coagulase negative 
staphylococcus had actually had an episode of true 
bacteremia (22). Therefore criteria are needed to assure 
that true positives are not eliminated along with the 
contaminants. 
Few studies have examined how to determine whether a 
culture is contaminated or truly positive. McGregor and 
Beatty (24) proposed a system that goes beyond looking only 




...patient's history and findings of physical 
examination, temperature course, white blood cell 
counts, results of other types of cultures, 
clinical course, presence of blood d/scrasias or 
intravenous polyethylene catheters, evidence of 
recent intravenous drug abuse... 
They also found that true positives were more likely to 
have multiple bottles positive (69%) than were contaminants 
(11%). 
For this study, the determination of case or 
contaminant status will be based on the following 
guidelines: 
1. Organism: certain organisms are found on the skin and 
therefore are more likely to appear as contaminants. 
For this reason, coagulase negative Staphylococcus 
will be considered a contaminant unless the patient is 
an intravenous drug abuser or has an indwelling 
catheter. Other organisms, such as E. coli, H. 
influenzae. Strep. pneumoniae, and gonorrhoeae 
rarely appear as contaminants and, therefore, will be 
considered true positives. 
2. Number of bottles positive: As per MacGregor (24) the 
contaminants are more likely to have multiple cultures 
positive when multiple cultures are taken, while 
contaminants are more likely to have fewer positive 
cultures. 
3. Patient * s predisposing factors: Includes intravenous 
drug abuse, indwelling prosthesis, valvular heart 
disease, diabetes. 
4. Other positive cultures: Finding the organism in the 
blood and at another infected culture site greatly 
supports the status of true positive. 
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Based on the above criteria, a judgement was made by 
two separate people as to whether the culture was indeed a 
true positive. It is important to remember that no criteria 
can classify true positives or false positives with 100% 
assurance. Theretore, two additional categories were 
created: Possible true positive and Possible contaminant. 
Thus, the positive cultures will be classified as: 
1. True Positive if there was little question that the 
organism was a true positive by the above criteria. 
2. Possible True Positive if most of the evidence pointed 
to the organism being a true positive but some doubt 
remained, or the two people evaluating the culture 
disagreed as to whether it was a true positive. 
3. Contaminant if there was little Huestion that the 
organism was a contaminant by the above criteria. 
4. Possible Contaminant if most of the evidence pointed 
to the organism being a contaminant but some doubt 
remained. 
For this study, only true positives will be used as 
cases in the case-control analysis. It is important to 
remember that the above attempts to categorize what is 




Clinical information from the emergency room visit was 
obtained from the emergency room record sheet and recorded 
on the extraction form (see appendix A.l). If the patient's 
permanent medical record could not be found, or if the sheet 
could not be located in the permanent record, the carbon 
copy, kept in the emergency room, was used. 
In order to reduce bias, cases and controls were 
extracted for all information (except for the variable, 
follow up) before the blood culture result was known. After 
recording the blood culture result the charts of patients 
with positive cultures were reexamined to determine if any 
follow-up occurred and to find any data that might be 
helpful in determining if the culture were a true positive 
(for instance, other culture results were sought). 
2.7 EXTRACTION FORM 
The extraction form was used to collect data thought to 
be related to the presence of bacteremia. Name and unit 
number were needed to locate the medical record. All data 
was pooled—no patient is individually identifiable. A copy 




The following subsections contain the definitions used 
to code the clinical and laboratory inrormation from the 
emergency room sheet onto the extraction form. 
z.8.1 DEMOGRAPHIC DATA 
Age, sex and race recorded as reported on the top of 
the emergency room sheet. 
2.8.2 VITAL SIGNS 
Temperature, blood pressure, and pulse recorded as 
reported on emergency room sheet. In the case of multiple 
entries the first entry was recorded. 
2.8.3 PREDISPOSING FACTORS FOR BACTEREMIA 
A number of predisposing factors are recorded in the 
literature (43), primarily from inpatient studies. Those 
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included on the extraction form are described below. 
2.8.3.1 INSULIN DEPENDENT DIABETES MELLITUS 
Reported as such on the emergency room sheet. Also 
acceptable is diabetes mellitus with insulin listed under 
medsf or as type I or juvenile onset diabetes mellitus. 
2.8.3.2 NON-INSULIN DEPENDENT DIABETES MELLITUS 
This predisposing factor recorded as positive in NIDDM 
is recorded on the emergency room sheet or if DM is recorded 
and oral hypoglycemics are listed under medications. 
2.8.3.3 INTRAVENOUS DRUG ABUSE 
This predisposing factor is considered positive if 
current use of intravenous drugs or a history of intravenous 
drug use is reported. 
2.8.3.4 IMMUNOSUPPRESSIVE DRUd USE 
This predisposing factor considered positive if patient 
is currently using or has recently used immunosuppressive 
drugs. 
2.8.3.5 SPLENECTOMY 
This predisposing factor considered positive if the 
patient has a history of surgical removal of the spleen or 
has functional splenectomy. 
2.8.3.6 ORuAN TRANSPLANT 
This predisposing factor recorded as positive if the 




History of cancer recorded on emergency room sheet. 
2.8.3.8 OTHER IMMUNujEFICIENCY 
Immunodeficiency not covered in the categories above 
(e.g. AIDS, agammaglobulinemia). 
2.8.3.9 VALVULAR HEART DISEASE 
Sufficient criteria include a history of valvular heart 
disease or rheumatic heart disease. The presence of a heart 
murmur is not sufficient. 
2.8.3.10 SICKLE CELL DISEASE 
History of sickle cell disease. 
2.8.3.11 IMPLANTED PROSTHESIS 
Includes heart valve, pacemaker, implanted pump, 
indwelling urinary catheter, artificial joint, or other 
permanent indwelling foreign body. 
2.8.3.12 GRANULOCYTOPENIA 
Absolute granulocyte count less than 1000 per cubic 
millimeter. 
2.8.4 BLOOD CULTURE RESULTS 
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The organisms present in the blood culture bottles were 
recorded from records kept by the blood culture laboratory. 
"1st bottle" indicates the aerobic bottled while the "2nd 
bottle" indicates anaerobic. Note that an aerobic/anaerobic 
set represents one blood culture. Also, both of the media 
will generally support the growth of most aerobes or 
anaerobes. 
2.8.5 HEMATOLOGY 
The values for leukocyte count with differential and 
erythrocyte sedimentation rate were recorded as reported on 
the emergency room sheet, or on the listing of these values 
provided by the laboratory computer. If more than one value 
is reported, the first is recorded. 
2.8.6 PYUHIA 
Pyuria is considered to be present if more than five 
white blood cells are present per high powered field (400x) 
in spun urine sediment (7). 

2.8.7 POSITIVE CHEST X-RAY 
21 . 
A chest x-ray is considered positive if it contains a 
new infiltrate or new area of consolidation. 
2.8.8 LOCATION OF INFECTION 
The location of infection was determined by evaluating 
all the data found on the emergency room sheet, then the 
author decided, on clinical grounds, as to the anatomical 
location of the infection. The specific definitions are 
found below. 
2.8.8.1 PNEUMONIA [PULMONARY] 
(NOTE: This location of infection was misprinted on the 
extraction form. It should have read "pulmonary infection" 
rather than "pneumonia" on the extraction form). It is 
defined by presence of cough, or productive cough with the 
abundance of a single organisms in the sputum, as evidenced 
by a sputum culture or gram stain, along with a positive 
chest x-ray (as defined above). 
2.8.8.2 OTiiER RESPIRATORY 
Defined as presence of cough or productive cough in 
aoseuce of a positive chest x-ray. It also includes 
inflammation or infection of the oropharynx or tonsils. 
2.8.8.3 URINARi TRACT INFECTION [UTI] 
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defined by the presence of urinary tract symptoms, 
including frequency, urgency, dysuria or costovertebral 
angle tenderness in conjunction with pyuria (>5 W3C/IIPF). 
2.a.8.4 CSF/MENINGES 
Presence of meningeal signs with nucleated cells 
present on lumbar puncture, if performed. 
2.8.8.5 SEPTICEMIA 
If the infection cannot be considered present primarily 
in another organ system, and the patient manifests the signs 
of septicemia, including fever, increased leukocyte count, 
and low blood pressure. 
2.8.8.6 GASTROINTESTINAL TRACT 
Nausea, vomiting or diarrhea in conjunction with 
abdominal pain or tenderness, with no evidence of 
non-gastrointestinal source (for instance, genito-urinary 
infection with abdominal pain.) 
2.8.8.7 SKIN INFECTION 
Presence of an abscess, cellulitis, impetigo, or 
recognizable exauthem. 
2.8.8.8 ENDOCARDITIS 
Characterized by new murmur or change in old murmur, 
with fever and characteristic signs for endovascular 
infection, including a new murmur or a change in an existing 
murmur splinter hemmorhages, Roth's spots, Janeway lesions. 
2.8.8.9 UNDETERMINED 
If the clinical data do not point to a specific organ 
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system as listed above, then the patient is placed in this 
category. 
2.8.9 DISCHARGED ON ANTIBIOTICS 
Yes if antibiotic is noted on emergency room sheet, no 
if otherwise. 
2.8.10 FOLLOW UP 
This variable is applicable only for patient's with 
positive olood cultures. f he patients chart was searched 
for evidence of either a follow-up visit to the emergency 
room or a follow-up telephone call from the emergency room. 
Due to limitations in data sources, follow-up to clinics or 
to private physicians is unknown. The specific definition 
of each type of follow-up can be found below. 
1. NO FoLLOW-UP is recorded if no evidence of follow-up 
can be found. 
2. RETURN TO EMERGENCE ROOM, NOT ADMITTED is recorded if 
evidence in the chart indicates that the patient 
returned to the emergency room for re-evaluation and 
was not admitted. This evidence could include an 
emergency room sheet from the follow-up visit or a 
note on the sheet from the initial visit. 
3. RETURNED TO EMERGENCY ROOM, ADMITTED: as in 2. above 
except the patient is admitted. 
4. OTHER includes telephone calls, or other communication 
with the patient. 
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5. NOT APPLICABLE: All controls were placed in this 
category since they would not be expected to be 
followed up. 
2.9 STATISTICS 
The data were entered into an IBM PC XT computer and 
analyzed using Perfect Calc software. The two tailed 
t-tests performed on the continuous variables were for 
independent groups. Yate’s correction was used in 
Chi-square calculations in two by two tables. When a table 
contained a cell with an expected value less than five, then 
Fischer’s exact test was used to determine the Chi-square. 
Epistat software was used to calculate chi-square and 
perform Fischer's exact test. In the calculation of odds 
ratios, for 2x2 tables that contained zero in one or more 
cells, a correction factor of 0.5 was added to each cell, as 




TABLES FROM CHAPTER 2, MATERIALS AND METHODS 

A.1 EXTRACTION FORM 26 DONE [; 
OUTPATIENT BLOOD CULTURES IN ADULTS: 
1. Naae: _ 2. Hospital Unit I: 
3. Study I:_ 4. ER Date_/_/_ 5. BC Date _ 
6. Age:_ 7. Sex _J1 =1 __F =2 8. Race_Caucasian [=11 _hispanic [=43 
_ black [=21 _ other (specify:) 
_ asian [=31 
_ not spec. [=91 
9. Teep.:_._ 10. BP:_/_ 11. Pulse: 
12. List up to four predisposing factors: 
(none) [=001 Other ieeunodeficiency 1=00] 
Insulin-dependant diabetes eellitus [=011 Valvular heart disease [=09] 
Non-insulin-dependant diabetes eellitus [=021 Sickle-cell disease [=111 
Intravenous drug use [=031 Ieplanted prosthesis [=121 
Iaeunosuppressive drug use [=041 Alcohol abuse [=131 
Spleenectoey [=051 Granulocytopenia [=141 
Organ transplant [=061 other disease (specify): 
Cancer [=071; type: 
13. Blood culture tl: 
14. Blood culture 12: 





1st bottle: _ 2nd bottle: 
[yes= orgamsa code; no=00; not done=99] 
contai.:_no [=01  yes [=11 
contaa.:_no [=01  yes [=11 
contaa.: _no [=01 ___yes [=1] 
16. White blood count: ... 17: ESR. 
18. I Segs . 19. 2 Bands . 20. llyaphs . 21. lALs 
22. Pyuria ( >5/HPF): _ no [=01   yes [=11 ___ not done [=91 
23. Positive chest x-ray:   no [=01   yes [=11   not done [=91 
24. Presuaed location of infection: 
_ pneuaonia [=011 _ septiceaia [=051 _ undeterained [09] 
_ other resp. [=023 _ GI tract [=06] _ other (specify): 
urinary tract [=033 _ skin infection [=07] 
_ CSF/Heninges [=04] _ Endocarditis [=08] 
26. Discharge diagnosis: __[=code] 
27. Discharged on antibiotics? _no [=0] _yes [=13 Type__ 
28. Foil oh up. 
_ no follow up [=13 _ other [=83_ 
_ returned to ER, not adait. [=23 _ not applicable [=93 
















































3.1 GENERAL DESCRIRTIVS STATISTICS 
The patients studied were taken from a computer list 
generated by the hospital computer information service. The 
list consisted of patients who had had blood cultures drawn 
in the emergency room between 1 February 1983 and 31 January 
1986. All those with growth reported were taken, along with 
a 10% random sample of those patients with no growth. A 
total of 262 patients with blood cultures were selected. 
After eliminating the patients who were admitted, 179 
remained: loO without growth in their blood cultures, and 79 
with growth. The emergency room sheets for two patients in 
each group could not be found. Thus, 98 of the 100 cases 





The 98 patients from the no growth group comprise the 
control group, representing a 10% sample of all those listed 
as "no growth". From now on they will be referred to as 
controls. 
3.1.2 CASES AND CONTAMINANTS 
The 76 patients represent 97.4% of all the outpatients 
with growth in their blood cultures. This group was further 
divided by the investigator and one advisor into four groups 
as follows: 
True Positives 21 
Probable True Postives 4 
Probable Contaminants 4 
Contaminants 48 
Total 77 
(The definitions for these categories can be found in the 
Materials and Methods chapter, section 2.6). Appendix B.l 
and 8.2 list the organisms found in cases and contaminants, 
respectively. Appendix B.3 lists the true positives, along 
with age, sex, number of bottles positive, and other 
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important clinical and laboratory data. Similarly, Appendix 
B.4 lists this information for the contaminants and probable 
contaminants. 
3.1.3 COMPARISON OF CONTROLS AND CONTAMINANTS 
Since much of the analysis of this essay rests on the 
comparison of cases and controls, it is important that the 
determination of true positivity be as accurate as 
possible. One assurance of this accuracy comes from careful 
application of the definitions pat forth in the Materials 
and Methods section. 
One way to assess the accuracy of case determination is 
to compare the contaminants to the controls. There should 
be no statistically significant difference between the 
control data and the contaminant data. Similarly 
contaminants should differ from cases in the same ways that 
controls differ from cases. 
A complete listing of the comparison between 
contaminants and controls is found in Appendix B.5. Briefly, 
this comparison revealed no statistically significant 
differences between contaminants and controls in all areas 
examined. The comparison between contaminants and cases is 
found in Appendix B.o. This second comparison revealed that 
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contaminants differed from cases statistically in the same 
way that controls differed from cases. 
3.2 PRhLlMINARi STATISTICS 
The case group was compared with the control group. 
Statistical tests performed include the chi-square test, the 
t-test and Fischer's exact test where appropriate. The 
results appear in the subsections below. When numeric 
results are presented in the text, case data will be given 
first, followed by control data, unless otherwise noted. 
T-test results on continuous variables will be given as mean 
+ standard deviation. 
Many results are expressed as odds ratios [OR]. An odds 
ratio greater than one indicates that the factor in question 
is positively associated with bacteremia, while an odds 
ratio less than one means that a factor is negatively 
associated with bacteremia. Also listed is a 95% confidence 
interval [Cl]. The odds ratio for any particular calculation 
has a 95% chance of lying somewhere in that interval. 
However, the reported odds ratio is the best estimate. If 
the confidence interval does not include unity [1], then the 
result is statisticly significant; if the confidence 





In comparing age, the cases and controls did not differ 
significantly [38.13 + 19.59 vs. 38.4 + 18.8]. There was no 
statistical difference in gender: Females represented 47.6% 
of the cases and 45.9% of the controls (p=Q.95). As for 
race, cases showed an increased proportion of non—caucasians 
(blacks and hispanics) when compared with controls [65.0% 
vs. 36.8% p=0.04]. A complete listing of the demographic 
data appears in Appendix B.7. 
3.2.2 VITAL SIuNS 
No statistically significant difference appeared in 
mean temperature (101.28 + 1.34 vs. 101.45 + 1.92, p=0.53), 
systolic blood pressure (124.8 + 20.7 vs. 127.2 + 22.5 
p=0.o4) or diastolic blood pressure (74.0 + 12.6 vs. 74.5 + 
18.2 p=0.92) or pulse (101 + 7 vs. 99 + 20. p=0.55). (See 
also Appendix B.8.) 
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3.2.3 PREDISPOSING FACTORS 
Only seven of the possible 13 predisposing factors 
appeared in either the case or control group. These seven 
are insulin dependent diabetes mellitus [IDDM], non-insulin 
dependent diabetes mellitus [NIDDM], intravenous drug abuse 
[IVDA], cancer , valvular heart disease, implanted 
prosthesis, and alcohol abuse. Over 38% of the cases had 
one or more predisposing factors, while only 28.6% of the 
controls had one or more predisposing factors, giving an 
odds ratio of 1.53. This difference was not statistically 
significant. 
Analysis of specific predisposing factors revealed no 
statistically significant differences between cases and 
controls in any of these seven groups. A detailed listing 
appears in Appendix B.9. 
3.2.4 LABORATORY DATA 
Comparison of leukocyte count [WBC] in cases and 
controls revealed a statistically significant increase in 
WBC in the case group (12.73 + 5.60 vs. 9.87 + 4.67 
p=0.02). A similar increase was found in the band count [% 
bands] (20.5 + 17.06 vs. 10.8 + 10.57 p=0.002). A 
statistically significant difference also appeared in the 
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segmented neutrophil count [% segs]. However, the mean 
percentage was lower in cases than in controls (59 + 15.02 
vs. 09 + 14.8 p=0.U07). No difference appeared in 
lymphocyte count, atypical lymphocyte count or total 
neutrophil count [% sess + % bands]. Erythrocyte 
sedimentation rate [ESR] showed no statistically significant 
difference. However, this test was performed on only 40 of 
the 121 cases and controls. (A complete listing of this 
information can be found in Appendix B.10). 
3.2.5 PYURIA 
Pyuria was found in 4 (19%) cases and 16 (16.2%) 
controls. This proved to be an insignificant difference. 
Pyuria was not tested in 33.3% of the cases and 53.1% of the 
controls. A full listing of the results appears in Appendix 
B. 11. 
3.2.6 CHEST X-RAY 
Statistically, a positive chest x-ray was no more 
likely to appear in cases than in controls, although there 
was a tendency in that direction as evidenced by an odds 
ratio [OR] of 2.7. This procedure was performed on only 
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6o.7% of cases and 4o.9% of controls. The results appear in 
Appendix B.ll. 
3.2.7 LOCATION OF INFECTION 
The analysis of location of infection, as defined in 
the previous chapter, produced several interesting results. 
Pulmonary infections accounted for 33.3% of the infections 
in cases and only 11.2% in controls (p=0.03) for an odds 
ratio of 3.95. Similarly, urinary tract infections [UTI] 
accounted for 23.8% of infections in cases and only 7.1% in 
controls (p=0.057) for an odds ratio of 4.10. Skin 
infections were found in 9.5% of the cases and 3.1% of 
controls (p=0.21) with an OR of 3.33. 
Two categories, other respiratory infections and 
undetermined infections, proved to be negative predictors 
with odds ratios less than 0.30. This means that there was a 
higher association between these two locations of infection 
and non-case status. However, neither of these associations 
proved statistically significant. Infections of the central 
nervous system, gastrointestinal tract, or other locations 
showed no significance. A complete table of locations of 
infection can be found in Appendix B.12. 

3.2.8 hISCHAKoE DIAGNOSIS 
Analysis of discharge diagnosis revealed that 33.3% of 
cases were discharged with pneumonia, while only 10% of 
controls were (p=0.016; 0R=4.4). Urinary tract infections 
accounted for 23.8% of cases and only 7.1% of controls 
(0R=4.0o, P=0.06), and cellulitis 9.5% cases and 3.1% 
controls (P=U.21 0R=3.33). However 24.4% of controls were 
discharged with viral syndrome, while jao cases were. 
Similarly, unideutiried fever was found only in controls 
(6.1%) and never in cases. Neurological/ETOH consisted of 
people who came in with neurological diseases such as 
seizures, syncopy, or ethanol withdrawl. The category 
'other' included cancer, pain, possible meningitis, 
metabolic disturbances, asthma, and congestive heart 




TABLES FROM CHAPTER 3, RESULTS 

B.l FREQUENCY OF ORGANISMS FOUND IN CASES 
ORGANISM FREQUENCY 
ESCHERICHIA COLI 5 
STREPTOCOCCUS PNEUMONIAE 5 
HAEMOPHILUS INFLUENZAE 2 
NEISSERIA oONORRiiOEAE 2 
SALMONELLA, oROUP B 2 
STaPHfLOCOCCUS AUREUS 1 
CAMPTLOBACTER JEJUNI 1 
PEPTOCOCCUS ASACCAROLTICUS 1 
PROVIDENTIA STUARTI 1 
STREPTOCOCCUS, uROUP A 1 
TOTAL 21 

B. 2 FREQUENCY OF ORGANISMS FOUND IN CONTAMINANTS 
ORGANISM 













Mixed: STAPH COAG. NEG. 
S. SALIVARIUS 





















13.3 CASES: BLOOD CULTURE RESULT, OTHER CULTURE 
RESULTS, AND OTHER CLINICAL INFORMATION 
AoE/ 
SEX 





53/M S. AUREUS 1/4 - IDDM 
CELLULITIS 
zd/M SALMONELLA 1/4 - - 
21/M STREP. PNEU. 2/2 — POS CXR 
17/M STREP GP A 1/2 THROAT - 
26/F N. gONORRHOEAE 1/2 — IVDA 
lo/F STkEP. PNEU. 1/4 - POS CXR 
91 /F PROV. STUART 3/4 URINE PYURIA 
3 o/A PEPToCOCCUS 1/2 — IVDA 
CELLULITIS 
4o/F H. FLU 1/4 - POS CXR 
2S/F STREP. PNEU. 2/2 SPUTUM POS CXR 
58/M E. COLI 1/4 - PYURIA 
48/M STREP. PNEU. 1/4 - POS CXR 
73/F CAMPILO. JEo. 1/2 — — 
32/F E. COLI 1/4 URINE PYURIA 
35/M SALMONELLA 1/4 - IVDA 
24/F E. COLI 4/4 URINE — 
26/F E. COLI 3/4 URINE - 
24/M H. FLU 4/4 - POS CXR 
??/? E. COLI 1/2 — PYURIA 
21/M STREP. PNEU. 1/2 — POS CXR 
5^/H N. GONORRHOEAE 1/2 - - 
* IDDM = INSULIN DEPENDANT DIABETES MELLITUS 
IVDA = IKTRA-VENOUS DRUG ABUSE 
NIDDM = NON INSULIN DEPENDANT DIABETES MELLITUS 
OSTEO = OSTEOME r LITIS 
PUS CIR = POSITIVE CHEST X-RAY 
PYURIA = GREATER THAN 5 WBC PER HPF 

B.4 CONTAMINANTS: BLOOD CULTURE RESULT, AND OTHER 
CLINICAL INFORMATION 
AGE/SEX ORGANISM BOTTLES POS OTHER * 
/TOTAL BOT. 
68/F STREP. VIRIDANS 1/2 NIDDM 
??/F STAPH. COAG. NEG. 2/2 NO PF 
29/M STAPH. COAG. NEG. 1/4 NO PF 
40/F STAPH. COAG. NEG. 1/2 IDDM 
30/M STAPH. COAG. NEG. 1/2 IVDA, ETOH 
21/F STAPH. COAG. NEG. 1/4 NO PF 
55/F STAPH. COAG. NEG. 1/4 CA 
31 /F AER. DIPHTHEROIDS 1/2 NO PF 
70/F STAPH. COAG. NEG. 2/4 CELLULITIS 
34/F BACILLIS CEREUS 1/4 NO PF 
63/M ** PROPRIONIBACTERIA 1/6 CA 
27/M ** PROPRIONIBACTERIA 1/2 IVDA/RHD 
32/M STREP. SALIVARIUS 1/4 NO PF 
47/F STAPH. COAG. NEG. 1/4 NO PF 
64/F STAPH. COAG. NEG. 2/2 CA 
23/M STAPH. COAG. NEG. 1/6 IVDA 
27/F STAPH. COAG. NEG. 2/6 NO PF 
60/F STAPH. COAG. NEG. 1/2 NO PF 
74/M BACILLIS CEREUS 1/4 NO PF 
99/F ** MIXED: S. C. NEG. 
STREP. SAL. 2/2 CA 
24/M STAPH. COAG. NEG. 1/6 NO PF 
28/M STAPH. COAG. NEG. 1/2 NO PF 
* CA « CANCER 
ETOH = ALCOHOL ABUSE 
IDDM = INSULIN DEPENDANT DIABETES MELLITUS 
IVDA = INTRAVENOUS DRUG ABUSE 
NIDDM = NON INSULIN DEPENDANT DIABETES MELLITUS 
NO PF = NO PREDISPOSING FACTORS 
RHD = RHEUMATIC HEART DISEASE 
** PROBABLE CONTAMINANT 
CONTINUED ON NEXT PAGE 

CONTINUATION OF APPENDIX B.4 
B.4 CONTAMINANTS: BLOOD CULTURE RESULT, AND OTHER 
CLINICAL INFORMATION 
AGE/SEX ORGANISM BOTTLES POS 
/TOTAL BOT. 
OTHER * 
46/M STAPH. COAG. NEG. 1/2 NO PF 
51/F BACILLIS SP. 1/4 IMP PROS 
25/M STAPH. COAG. NEG. 1/4 IVDA 
21/F STAPH. COAG. NEG. 1/2 NO PF 
21/M STREP. SANGUIS 1/4 NO PF 
22/M AER. DIPHTHEROIDS 1/2 SICKLE CELL 
56/M STAPH. COAG. NEG. 1/4 NO PF 
23/F STAPH. COAG. NEG. 1/4 IVDA 
59/F MIXED: S. C. NEG. 
STREP. VIR. 2/2 NO PF 
77/F NEISSERIA SUBFLAVA 1/4 NO PF 
24/M PROPRIONIBACTERIA 1/4 NO PF 
18/F STAPH. COAG. NEG. 1/2 NO PF 
52/F PROPRIONIBACTERIUM 1/2 IDDM 
43/F STAPH. AUREUS 2/2 NO PF 
31/M PROPRIONIBACTERIA 1/2 
GASTRITIS 
NO PF 
23/F BACILLIS SP. 1/4 NO PF 
27/M BACTEROIDES 1/2 NO PF 
72/M STAPH. COAG. NEG. 2/4 NIDDM 
23/F STAPH. COAG. NEG. 1/2 NO PF 
52/M STAPH. COAG. NEG. 1/4 NO PF 
22/F STAPH. COAG. NEG. 2/6 IVDA 
25/M ** MICROCOCCUS 1/4 IVDA 
19/M STAPH. COAG. NEG. 1/2 NO PF 
36/M BACILLIS 1/2 NO PF 
59/F STAPH. COAG. NEG. 1/2 NO PF 
27/F STAPH. COAG. NEG. 1/2 NO PF 
35/M STAPH. COAG. NEG. 1/2 IVDA, ETOH 
64/F BACILLIS POPILLIAE 1/4 NO PF 
36/M STAPH. COAG. NEG. 1/4 IVDA 
* IDDM = INSULIN DEPENDANT DIABETES MELLITUS 
IMP PROS = IMPLANTED PROSTHESIS 
IVDA = INTRAVENOUS DRUG ABUSE 
NIDDM - NON INSULIN DEPENDANT DIABETES MELLITUS 
NO PF = NO PREDISPOSING FACTORS 
** PROBABLE CONTAMINANT 

B.5 COMPARISON OF CONTAMINANTS AND CONTROLS 
FEATURE CONTAMINANTS CONTROLS P * 
N- 52 N= 98 
AGE 41.4 + 19.5* ** 38.4 + 18.8 0.63 
TEMPERATURE 101.2 ± 1-7 101.5 + 1.92 0.53 
SYSTOLIC BP 127.7 + 20.7 127.2 + 22.5 0.91 
DIASTOLIC BP 74.2 + 16.2 74.5 + 18.2 0.92 
PULSE 97.0 ± 19.0 99.0 + 20.0 0.65 
LEUKOCYTE 
COUNT 10.1 + 5.0 9.9 + 4.7 0.79 
% SEGS 70.0 + 16.0 69.2 + 14.9 0.77 
%BANDS 7.9 + 10.0 10.8 + 10.5 0.11 
SEX 
MALE 24 (46.2)*** 53 (54.1) 
FEMALE 28 (53.8) 45 (45.9) 0.45 
RACE 
WHITE 26 (50.0) 61 (62.2) 
NON-W 26 (50.0) 36 (37.8) 0.18 
# P. F. 
0 31 (59.6) 70 (71.4) 
1 17 (32.7) 23 (23.5) 
1 or 2 21 (40.4) 28 (28.6) 0.20 
* VALUE CALCULATED BY CHI-SQUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 
** MEAN + S.D. 
*** COUNT (PERCENT) 







AGE 41.4 + 19.5** 43.9 + 23.8 0.64 
TEMPERATURE 101.2 + 1.7 101.2 + 1.3 0.99 
SYSTOLIC BP 127.7 + 20.7 128.3 + 20.1 0.89 
DIASTOLIC BP 74.2 + 16.24 72.8 + 11.9 0.72 
PULSE 97.1 + 18.8 100.5 ± 7-7 0.61 
LEUKOCYTE 
COUNT 10.1 + 5.0 12.3 + 5.4 0.09 
% SEGS 70.0 + 16.0 60.8 + 14.6 0.02 
%BANDS 7.9 + 10.0 19.3 + 16.0 <0.01 
SEX 
MALE 24 (46.2)*** 11 (52.4) 
FEMALE 28 (53.8) 10 (48.6) 0.93 
RACE 
WHITE 26 (50.0) 7 (35.0) 
NON-W 26 (50.0) 13 (65.0) 0.67 
# P. F. 
0 31 (59.6) 13 (61.9) 
1 17 (32.7) 10 (38.1) 
2 4 ( 7.7) 0 ( 0.0) 0.83 
* P-VALUE CALCULATED BY CHI -SQUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 
** MEAN + S.D. 
*** COUNT (PERCENT) 
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B. 7 DEMOGRAPHIC DATA: CASES VS. CONTROLS 
FEATURE CASES CONTROLS OR 95% Cl P * 
N=21 N= 98 
SEX M 11 (52.4) 53 (54.1)*** 
F 10 (47.6) 45 (45.9) 0.93 (0.33-2.64) 0.92 
RACE 
W 7 (35.0) 61 (62.2) 
B 13 (65.0) 32 (32.7) 
H 0 ( 0.0) 4 ( 4.1) 
B+H 13 ( 0.0) 36 ( 1.0) 0.32 (0.01-0.96) 0.04 
FEATURE CASES CONTROLS P * 
AGE 38. 2 + 19. 6** 38.4 + 18.9 0.97 
B.8 VITAL SIGNS: CASES VS. CONTROLS 
FEATURE CASES CONTROLS P * 
TEMP. 38.15 + 19.59 38.35 + 18.78 0.97 
SYS. BP 129.8 + 20.7 127.2 + 22.5 0.64 
DIAS. BP 74.1 + 12.6 74.5 + 18.2 0.92 
PULSE 101 + 12 99 + 20 0.55 
* P-VALUE CALCULATED BY CHI-SyUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 
*» MEAN + S.D. 
*** COUNT (PERCENT) 
• 





OR P ** 
IDDM 
Y 1 ( 4.8) 1 ( 0.8)*** 
N 20 (95.2) 97 (97.0) 4.85 0.32 
NIDDM 
Y 0 ( 0.0) 3 ( 3.1) 
N 21 (100.0) 95 (96.9) 0.75 0.56 
I VDA 
Y 3 (14.3) 13 (13.3) 
N 18 (85.7) 85 (86.7) 1.09 0.56 
CANCER 
Y 1 ( 4.8) 3 ( 3.1) 
N 20 (95.5) 95 (96.9) 1.58 0.55 
VHD 
Y 0 ( 0.0) 5 ( 5.1) 
N 21 (100.0) 93 (94.9) 0.40 0.37 
IMP PROS 
Y 1 ( 4.8) 1 ( 1.0) 
N 20 (95.2) 97 (99.0) 4.85 0.32 
ETOH 
Y 2 ( 9.5) 7 ( 7.1) 
N 19 (90.5) 91 (92.9) 1.37 0.50 
* IDDM = INSULIN DEPENDANT DIABETES MELLITUS 
NIDDM = NON INSULIN DEPENDANT DIABETES MELLITUS 
IVDA = INTRAVENOUS DRUG ABUSE 
VHD = VALVULAR HEART DISEASE 
IMP PROS = IMPLANTED PROSTHESIS 
ETOH = ALCOHOL ABUSE 
** P-VALUE CALCULATED BY CHI-SQUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 
*** COUNT (PERCENT) 

B.10 LABORATORY DATA: CASES VS. CONTROLS 
FEATURE * CASES 
N=21 
CONTROLS 
N = 98 
P ** MISSING 
WBC 12.73 + 5.6*** 9.9 . + 4.7 0.02 1 
% SEGS 59.0 + 15.0 69.2 + 14.9 <0.01 3 
% BANDS 20.6 + 17.1 10.8 + 10.6 <0.01 2 
% LYMPHS 13.3 + 10.8 12.0 + 10.1 0.84 2 
% ATYP. 
LYMPHS 0.8 + 1.3 0.8 + 2.7 0.98 2 
% SEG + 
BANDS 79.6 + 14.2 79.9 + 12.1 0.92 3 
ESR 20.0 + 11.8 30.8 + 17.5 0.20 81 
ABS SEGS 7.6 + 3.9 7.0 + 3.5 0.51 3 
ABS BANDS 3.1 + 3.0 1.2 + 1.5 <0.01 3 
ABS SEG+ 
BAND 10.6 ± 5-7 8.1 + 4.2 0.03 3 
* WBC = LEUKOCYTE COUNT 
ESR = ERYTHROCYTE SEDIMENTATION RATE 
ABS = ABSOLUTE COUNT: (% CELL TfPE) X WBC 
** P-VALUE CALCULATED BY CHI-SQUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 
*** COUNT (PERCENT) 







OR 95% Cl P * 
PYURIA 
YES 4 (19.0)** 16 (16.2) 
NO 10 (47.6) 35 (35.4) 0.88 (0.19-3.73) 0.49 
NOT DONE 7 (33.3) 52 (53.1) 
POS CXR 
YES 6 (28.6) 10 (10.2) 
NO 8 (38.1) 36 (36.7) 2.7 (0.63-11.53) 0.22 
NOT DONE 7 (33.3) 52 (53.1) 
* P-VALUE CALCULATED BY CHI-SQUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 
** COUNT (PERCENT) 
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B.12 LOCATION OF INFECTION: CASES VS. 
CONTROLS 
FEATURE CASES CONTROLS OR 95% Cl P * 
PULM 7 (33.3) 11 (11.2) 3.95 (1.14-13.5) 0.03 
OTHER 
RESP 1 ( 4.8) 15 (15.3) 0.28 (0.02-2.21) 0.18 
UTI 5 (23.8) 7 ( 7.1) 4.1 (0.97-16.8) 0.06 
CNS 0 ( 0.0) 3 ( 3.1) 0.63 - 0.56 
01 2 ( 9.5) 12 (12.2) 0.75 (0.01-4.04) 0.21 
SKIN 2 ( 9.5) 3 ( 3.1) 3.33 (0.14-27.1) 0.21 
UNDET. 3 (14.3) 38 (38.8) 0.26 (0.06-1.03) 0.44 
OTHER 1 ( 4.8) 9 ( 9.2) 0.49 (0.01-4.23) 0.44 
TOTAL 21 98 
* P-VALUE CALCULATED BY CHI-SQUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 
** COUNT (PERCENT) 

B.13 DISCHARGE DIAGNOSIS: CASES VS. CONTROLS 
FEATURE CASES CONTROLS OR 95% Cl P * 
VIRAL 
SYND 0 ( O.O) 24 (24.5) 0.07 . <0.01 
PNEUMONIA 7 (33.3) 10 (10.2) 4.4 (1.25-15.4) 0.02 
UTI 5 (23.8) 7 ( 7.1) 4.06 (0.97-16.8) 0.06 
CELLULIT. 2 ( 9.5) 3 ( 3.1) 3.33 (0.13-27.1) 0.21 
GI 3 (14.3) 10 (10.2) 1.46 (0.12-6.67) 0.41 
OTHER 
RESP. 1 ( 4.8) 10 (10.2) 0.44 — 0.39 
UNIDENT 
FEVER 0 ( 0.0) 6 ( 6.1) 0.33 — 0.30 
OTHER INF 1 ( 4.8) 8 ( 8.2) 0.56 - 0.50 
NEURO/ 
ETOH 1 ( 4.8) 5 ( 5.1) 0.93 — 0.71 
OTHER 1 ( 4.8) 15 (15.3) 0.28 - 0.18 
TOTAL 21 98 
* P-VALUE CALCULATED BY CHI-SQUARE, T-TEST, 
OR FISCHERS EXACT TEST WHERE APPROPRIATE. 





4.1 COHORT CALCULATIONS 
Even though the above calculations have been performed 
in a case-control format, it is possible to calculate rates 
from the data collected, because the controls were drawn as 
a random 10% sample of the total population without growth. 
Therefore it represents an unbiased sample of all patients 
with negative cultures. 
The best estimate of the total number of outpatients in 
the three year period without growth is 10x100=1000, since 
the 100 controls represent 10% of the total. A confidence 
interval for this estimate can be calculated (17), but since 
the best statistical estimate is 1000, this is the number 
that will be used in subsequent computations. 
Combining the 1000 no-growth cultures with the 77 cases 
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and contaminants yields 1077 patients over the three year 
period. This number will be used as the overall denominator 
for subsequent calculations. It represents the best 
estimate of all the patients seen in the ER who had at least 
one set of blood cultures taicen and were not admitted. 
4.1.1 RATES 
Cultures were taken from a total of 1077 outpatients 
over three years, or from approximately 357 patients per 
year. Since the medicine branch of the emergency department 
evaluates approximately 20,000 patients per year, this means 
that approximately 1.8% of patients have blood cultures 
taken in the emergency room. However this number 
underestimates the actual percentage of cultures taken in 
outpatients, since the denominator, 20,000, includes both 
outpatients and patients who were admitted. 
The overall positivity rate (both contaminants and true 
positives) is 77/1077 = 7.1%. The true positivity rate is 
21/1077 = 1.9%. The contamination rate is 52/1077 = 4.8%. 
These figures are comparable to those in Stair’s (44) and 




After the data were collected, but prior to analysis, a 
number of hypotheses were formulated as to what factors 
would be positive or negative predictors for bacteremia. 
The results are shown in Appendices C.l and C.2. 
4.2 PREDICTORS OF BACTEREMIA 
These data can also be used to help the clinician in 
the emergency room setting, decide whether or not to take a 
blood culture. The results of the following analyses are 
not applicable to all emergency room patients: Since the 
patients in this study were those who had BCs taken, 
presumably the house officer in the emergency room thought 
s/he was bacteremic. Thus the source population is a subset 
of the general emergency room population—the subset of 
outpatients who may be bacteremic. Therefore in order to 
apply the following results, the patient 
1. must be seen in the emergency room 
2. is going to be discharged 
3. is suspected to be bacteremic 
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If all three of the above criteria are fulfilled, then 
the following rules will apply. 
4.2.1 POSITIVE PREDICTORS 
As mentioned in the results section, there are several 
positive predictors for an increased risk of bacteremia. 
These include non-white race, and a pulmonary or urinary 
tract location of infection. In addition, the mean 
leukocyte count [WBC], and mean % band count were both 
significantly higher in cases than in controls. 
4.2.1.1 LEUKOCYTE COUNT [WBC] 
Further examination of the leukocyte count revealed 
that it is a useful predictor of bacteremia. Patients with 
a leukocyte count greater than 15,000 were more likely to be 
bacteremic (OR = 2.S) but this result was not statistically 
significant. However, a leukocyte count greater than 20,000 
proved to be a better predictor with an odds ratio of 7.9 
(p=0.02). Therefore, WBC greater than 20,000 is a 
significant positive predictor for bacteremia. However^ 
only 4 (20%) cases and 3 (3.1%) controls had a leukocyte 
count greater than 20,000. Although this may produce a 
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statistically siguiiicant result, it is of 4uestionable 
value since so few patients had leukocyte counts greater 
than 20,000. 
4.2.1.2 BAND COUNT 
The band count also proved to be a useful predictor of 
bacteremia. Eight cases (40%) had a band count greater than 
30%, while only 5 controls (3.1%) had a band count greater 
than 30% (Ok=12.25, p<.001). Thus % band count has a 
statistically significant positive association with 
bacteremia. 
Not surprisingly, the absolute band count (calculated 
by multiplying % bands by leukocyte count) showed a similar 
association. Eleven cases (55%) had an absolute band count 
greater than 2000, while only 14 (14.6%) of controls did (OR 
= 7.6 95% Cl = 2.24 - 23.38). This cut-off point of 2,000 is 
clinically reasonable—Wintrobe (49) reports the mean number 
of bands found in normal controls as 630 + 410, with a range 
of 0-1450. Therefore a count greater than 2000 would be well 
above the normal range, and be a more specific test for an 
elevated band count. 
The list of statistically significant positive 
predictors now includes the following: 
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1. Leukocyte count greater than 20,000 
2. Band count greater than 30% 
3. Absolute band count greater than 2,000 
4. Race, non-caucasian 
5. Location of infection: pulmonary or urinary tract 
4.2.1.3 NEGATIVE PREDICTORS 
Only one statistically significant negative predictor 
appeared in the results: the discharge diagnosis of viral 
syndrome. However a discharge diagnosis is difficult to 
apply in the clinical setting. More applicable and useful 
information may be gleaned from the location of infection 
category. Even though the results are not statistically 
significant, the locations of infection of "other 
respiratory" and "undetermined" gave odds ratios of 0.12 and 
0.26 respectively (see Appendix B.12). Thus, both were 
strongly negative predictors. Other possibly helpful 
negative predictors include a leukocyte count less than 
5,000 (or possibly < 10,000), absolute band count less than 
2000, or % bands less than 5% (Appendix C.2). 

56. 
4.3 APPLICATION ON POSITIVE AND NEGATIVE PREDICTORS 
It may be possible to apply the predictors found above 
to the clinical setting. The scenario would be something 
like this: A house officer has seen a patient in the 
emergency room and thinks s/he may be may be bacteremic. 
However s/he does not appear to be sick enough to be 
admitted to the hospital. The house officer needs some data 
base to assist him or her in deciding whether or not to take 
a blood culture before discharging the patient. 
Individual predictors may be of some help. For 
instance, if the patient has an absolute band count greater 
than Z,JUO, since the OR is 7.1, s/he will have a greater 
chance of being bacteremic than a similar patient with an 
absolute band count less than 2,000. Other predictors can 
similarly be applied in this situation. 
Taking more than one predictive factor at a time will 
provide greater predictive ability than individual factors. 
For example, one study found that while a patient with one 
of a possible five predisposing factors may have a four fold 
greater chance of having a bacterial infection, having three 
of the five factors produces an 11.5 fold increase (32). 
The above is an example of a clinical prediction rule 
which "reduce(s) the uncertainty inherent in medical 
practice by defining how to use clinical findings to make 
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predictions" (48). In order to be useful, a good clinical 
prediction rule must define both the outcome event and the 
predictive findings well. In addition, the predictors 
should be readily available to the clinician. 
Three predictors were chosen since they are all 
statistically significant in this analysis, are easily 
obtained, and readily applied by the clinician. 
1. RACE; non-caucasian 
2. ABSOLUTE BAND COUNT; >2000 
3. LOCATION OF INFECTION; Pneumonia, urinary tract 
infection, or skin/soft tissue infection. 
The results are as follows: 
# OF 
FACTORS 
CASES CONTROLS OR * 95% Cl 
0 0 ( 0.0) 44 (44.9) 1.0 - 
1 10 (47.6) 39 (39.8) 23.7 (1.3- 417.0) 
2 o (28.6) 13 (13.3) 42.9 (2.3- 810.8) 
3 5 (23.8) 2 ( 2.0) 195.8 (8.3-4629.0) 
TOTAL 21 98 
*0das ratio using patients with no predictive factors as the 
referrant group. 
Since one of the cells contains zero value [0], the 
odds ratio estimate is arrived at by adding 0.5 to each 
cell, then calculating the odds ratio (as described in 
Fleiss (17). Since the 95% confidence interval does not 
contain unity [1] for one, two, or three factors, all of 

these results are statistically significant. The above 
table demonstrates that the more predictive factors present, 
tne more likely the patient is to be bacteremic, with an 
impressive gradient in the odds ratio. Also remarkable is 
the fact that all cases have at least one of the predictive 
factors, and only 2% of the controls have all three factors, 
while 23.o% of the cases have all three. 
The information in the above table could be applied in 
the clinical setting to help the physician in the emergency 
room in deciding whether or not to take a blood culture, 
since bacteremia is associated with an absolute band count 
greater than 2000, non-white race, and pneumonia, urinary 
tract infection or skin/soft tissue infection. 
4.4 COST 
A total of 1072 cultures were taken and an average of 
1.6 bottles per person yields approximately 1715 sets of 
cultures over three years. The culture bottles and 
eHuipment to draw the blood costs about $4.00. Currently the 
laboratory charges $14.00 to process one set of BC 
regardless of whether or not they are positive. Thus, the 
total cost of outpatient blood cultures over three years is 
■ 
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1715 X $18.00 = $50,820, or about $10,000 per year. The 
blood culture lab processes about 18,000 blood cultures per 
year, hence the blood cultures from adult medical 
outpatients represent only about 3.1% of the cultures 
processed. 
4.5 FOLLOtfUP 
A retrospective study such as this presents many 
difficulties in determining exactly what type of benefits 
are derived from taking these blood cultures (23). The data 
show that five out of 21 patients with positive cultures 
were followed up in the Yale-New Haven Emergency Room. None 
of these follow up visits appeared to result in a change of 
therapy. However, this does not mean that the remaining 16 
patients received no follow up. They could have visited 
another ER, or a clinic or their private physician. This 
lack of information makes any cost-benefit analysis (14) 




This study shows that blood cultures are rarely true 
positives, with a 1.9% positivity rate. In the case of 
fale-Hew Haven Hospital, this weans only 7 outpatient 
cultures are positive per year, out of approximately 350. 
The contamination rate is over twice the true positive rate 
(4.9%). Thus, if a culture is positive, it is more likely to 
be a contamiuant than a true positive. 
This investigation demonstrates that some factors, 
namely non-caucasian race, an absolute band count greater 
than 2,GOO and a site of infection of pneumonia, urinary 
tract infection, or sicin/soft tissue infection are all 
positive predictors for bacteremia. All cases had at least 
one of these factors, and as more factors were present, the 
likelihood of bacteremia increased. Over three fourths 
(d4.7%) or the controls had one or fewer predictive factors 
and almost half (44.9%) had none of these three factors. 
Considering the low positivity rate and high 
contamination rate in outpatient blood cultures, one may 
question why blood cultures are taxen at all. The primary 
reason is that the consequences of bacteremia can be so 
serious that no one wants to taKe the chance of not 
detecting it. The relatively benign procedure of taking a 
blood culture may provide an early lead on a potentially 
dangerous blood-borne organism, and may also prevent costly 
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admissions to "rule out" sepsis. Alternatively, taking 
blood cultures is costly and increases the hospitals 
responsibility tor tracking down and treating patients with 
positive cultures (42). 
The results of this study can be applied in the 
clinical setting to focus blood culturing on patients in 
whom bacteremia is most likely; that is those with two or 
more predisposing factors. In addition, since almost half 
of the controls had no predisposing factors, and all cases 
had at least one predisposing factor, patients with a low 
likelihood of bacteremia (i.e. no predisposing factors) can 
now be avoided, saving the time, cost, effort and pain of 
taking unnecessary blood cultures. 
4.7 KECOMMENOATIONS 
Further research on this topic should include a 
prospective cohort study, which would improve on this case 
control study in several ways. It would provide more 
accurate clinical and laboratory data. Other cultures fron 
the patient could be followed up more readily, and the 
patient could be contacted more easily, if needed, for 
follow-up information. In addition, the house officers 
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could be asked why they decide to take a blood culture from 
a particular patient, and how they determine whether a 




TABLES FROM CHAPTER 4, DISCUSSION 
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C.l FACTORS iiYPOTHESIZED TO INCREASE RISK OF 
BACfERErllA 
FACTOR ODDS RATIO P HELPFUL PREDICTOR 
AGE>55 0.96 0.81 NO 
AoE>7 0 1.13 0. o2 NO 
TEMP>101.0 2.0 0.29 POSSIBLE 
TEMP>102.5 0.67 0.66 NO 
WBC>15K 2.8 0.13 YES BUT NOT SIG. 
WBC>2OK 7.9 0.02 lES 
£SR>25 _ _ DONE IN <50% 
ESR>35 - - 
POS CXR - - DONE IN <50% 





0.37 SUGGESTIVE BUT 
NOT SIG. 
IDDM 4.85 0.32 NO, NOT SIG. 
IVDA 1.10 u.57 NO 
VHD 0.0 0.37 NO 
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C.2 FACTORS HYPOTHESIZED TO DECREASE RISK OF 
BACTEREMIA 
FACTOR ODDS RATIO P HELPFUL PREDICTOR 
AoE<50 0. S6 0.96 NO 
TEMP<1O0 O.S8 0.55 NO 
WO PF 0.65 0.54 NO 
WBC<10K 0.57 0.37 NO 
%SEGS<60 3.90 0.01 NO-POS.PRED 
%BANdS<5 0. j2 0.35 SUGGESTIVE BUT 
NOT SIG. 
WO PtURIA - - DONE IN <50Z 
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